Perbedaan Cipta Sarana Medika Tbk. dan UBC Medical Indonesia Tbk.: Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 3,7× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Cipta Sarana Medika Tbk. lebih aktif diperdagangkan (8,21 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DKHH | LABS | |
|---|---|---|
Kapitalisasi Pasar | 158,12 M | 584,6 M |
Volume | 8,21 jt | 817,3 rb |
Lot | 82,15 rb | 8,17 rb |
Perputaran | 515,2 jt | 120,01 jt |
Harga Rata-rata | 62,72 | 146,84 |
Nilai Transaksi | 515,2 jt | 120,01 jt |
Harga Ekuilibrium Indikatif | 63 | 146 |
Volume Ekuilibrium Indikatif | 1,33 rb | 59 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →